GSK and Alector announce global collaboration in immuno-neurology for two clinical stage…
GlaxoSmithKline plc and Alector announced a strategic global collaboration for the development and commercialisation of two clinical-stage, potential first-in-class monoclonal…
Read More...
Read More...